Business · 19/10/2018Updated: 10/17/2026 · 1 min read
Sanofi-Aventis, U.S., LLC, et al. Withdrawal of FDA Approval of 20 New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing the approval of 20 new drug applications from multiple applicants, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →